TrialBMJ open2019

Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.

Rupert Richard Alexander Bourne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.